Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, announced today that it has filed an application to list the Company’s common stock on the NASDAQ Capital Market. In addition, the Company’s Board of Directors has, subject to stockholder approval, approved proposals to rename the Company “Heron Therapeutics, Inc.” and to implement a reverse split of its common stock. The reverse stock split will be implemented in support of the Company’s NASDAQ listing application at a specific ratio within the range of 1:10 to 1:20, as fixed by the board following stockholder approval.
Help employers find you! Check out all the jobs and post your resume.
